These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2525990)

  • 21. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
    Greenberg PL
    Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
    [No Abstract]   [Full Text] [Related]  

  • 22. Modulation by cAMP of 1alpha,25-dihydroxyvitamin D3 sensitivity of murine erythroleukemia cells.
    Waki M; Inaba M; Hiura Y; Nagasaki T; Imanishi Y; Ishimura E; Otani S; Nishizawa Y
    Arch Biochem Biophys; 2001 Jul; 391(2):265-70. PubMed ID: 11437358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A group of deltanoids (vitamin D analogs) regulate cell growth and proliferation in small cell carcinoma cell lines.
    Güzey M; DeLuca HF
    Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):3-18. PubMed ID: 9434311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of cell growth, differentiation, and production of interleukin-3 by 1 alpha,25-dihydroxyvitamin D3 in the murine myelomonocytic leukemia cell line WEHI-3.
    Abe J; Moriya Y; Saito M; Sugawara Y; Suda T; Nishii Y
    Cancer Res; 1986 Dec; 46(12 Pt 1):6316-21. PubMed ID: 3490908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
    Levy Y; Knutson JC; Bishop C; Shany S
    Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
    Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
    Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells.
    McCarthy DM; San Miguel JF; Freake HC; Green PM; Zola H; Catovsky D; Goldman JM
    Leuk Res; 1983; 7(1):51-5. PubMed ID: 6682163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of different glucocorticoids on the in vitro cell kinetics of human hematopoiesis represented by a bone marrow culture and by phytohemagglutinin- and pokeweed mitogen-stimulated blood cultures].
    Boll I
    Onkologie; 1986 Feb; 9(1):30-5. PubMed ID: 3523344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of low-dose 1-hydroxyvitamin D3 in a patient with myelodysplasia after induction therapy for acute myelocytic leukemia.
    Fujisawa S; Motomura S; Sakai R; Tomita N; Fujimaki K; Mohri H; Okubo T
    Anticancer Drugs; 1997 Jun; 8(5):466-7. PubMed ID: 9215609
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hemocytology and molecular hematology].
    Kozinets GI; Shishkanova ZG; Reshchikov VP; Bykova IA; Pogorelov VM
    Probl Gematol Pereliv Krovi; 1979 Sep; 24(9):9-16. PubMed ID: 386302
    [No Abstract]   [Full Text] [Related]  

  • 32. Deferoxamine-induced restoration of haematopoiesis in myelofibrosis secondary to myelodysplasia.
    Marsh JH; Hundert M; Schulman P
    Br J Haematol; 1990 Sep; 76(1):148-9. PubMed ID: 2223635
    [No Abstract]   [Full Text] [Related]  

  • 33. Interferons as biologic modulators of hematopoietic cell proliferation and differentiation.
    Carlo Stella C; Cazzola M
    Haematologica; 1988; 73(3):225-37. PubMed ID: 2458997
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of 1,25-dihydroxy-vitamin D3(1,25(OH)2D3) in the treatment of idiopathic myelofibrosis.
    Eugster C; Brun del Re GP; Bucher U
    Br J Haematol; 1987 Mar; 65(3):381. PubMed ID: 3567092
    [No Abstract]   [Full Text] [Related]  

  • 35. 1,25-Dihydroxy-vitamin D3 (1,25(OH)2D3) in the treatment of idiopathic myelofibrosis.
    Petrini M; Cecconi N; Azzara A; Ambrogi F; Grassi B
    Br J Haematol; 1986 Nov; 64(3):624-5. PubMed ID: 3790450
    [No Abstract]   [Full Text] [Related]  

  • 36. Limited activity of luspatercept in myelofibrosis and myeloid neoplasms other than myelodysplastic syndromes with ring sideroblasts.
    Gangat N; Chetram D; McCullough K; Al-Kali A; Begna K; Hogan W; Litzow M; Foran J; Badar T; Palmer J; Patnaik M; Pardanani A; Tefferi A
    Am J Hematol; 2022 Dec; 97(12):E474-E477. PubMed ID: 36197043
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperfibrotic myelodysplasia: a report of three cases showing haematological remission following treatment with prednisolone.
    Watts EJ; Majer RV; Green PJ; Mavor WO
    Br J Haematol; 1991 May; 78(1):120-2. PubMed ID: 2043466
    [No Abstract]   [Full Text] [Related]  

  • 38. 1,25 Dihydroxy-vitamin D3 (1,25 (OH)2 vit D3) in the treatment of idiopathic myelofibrosis.
    Duncombe AS; Pearson TC; Nunan TO; Miller A; McCarthy DM
    Br J Haematol; 1987 Aug; 66(4):579-80. PubMed ID: 3663514
    [No Abstract]   [Full Text] [Related]  

  • 39. A population-based study of acute panmyelosis with myelofibrosis in the United States: 2004-2015.
    McLaughlin N; Ruan G; Day CN; Harmsen WS; Smith CJ; Binder M; Gangat N; Go RS; Tefferi A; Shah MV
    Am J Hematol; 2022 Apr; 97(4):E144-E147. PubMed ID: 35025125
    [No Abstract]   [Full Text] [Related]  

  • 40. Highlights in myelodysplastic syndromes from the 61st American Society of Hematology Annual Meeting.
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 5(2):1-24. PubMed ID: 33843919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.